Related Experiment Video

Updated: Aug 23, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Candidate antigens for an asexual blood-stage vaccine

R F Anders1

  • 1The Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria 3050, Australia.

Parasitology Today (Personal Ed.)
|December 1, 1985
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Related Experiment Videos

Last Updated: Aug 23, 2026

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens
06:03

Whole Blood Assay with Dual Co-Stimulation for Antigen-Specific Analysis of Host Immunity to Fungal and Viral Pathogens

Published on: September 20, 2024

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Articles linked to this work by shared authors, journal, and citation graph.

The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody.

Infection and immunity·2006

Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides.

Protein engineering·2001

Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii.

Molecular and biochemical parasitology·2001

Specificity of the protective antibody response to apical membrane antigen 1.

Infection and immunity·2001

Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species.

Molecular microbiology·2000

Malaria vaccines.

Parasitology today (Personal ed.)·2000

Immune effector mechanisms in parasitic infections.

Parasitology today (Personal ed.)·2006

Nitric oxide in health and disease.

Parasitology today (Personal ed.)·2006

Infection, oxford general practice series 40.

Parasitology today (Personal ed.)·2006

Parasitism and the platyhelminthes.

Parasitology today (Personal ed.)·2006

The application of attributable risk analysis in helminth epidemiology.

Parasitology today (Personal ed.)·2006

The Search for Novel Malaria Transmission-blocking Targets in the Mosquito Midgut.

Parasitology today (Personal ed.)·2006

Immune-epigenetic convergence in biomaterial-guided tissue regeneration.

Materials today. Bio·2026

Functionalized bio-patches for intra-abdominal applications.

iScience·2026

Early immune cell development precedes gastrulation in annual killifish.

bioRxiv : the preprint server for biology·2026

Poly(hydroxybutyrate) nanoparticle-encapsulated albendazole enhances in vivo efficacy against the Echinococcus multilocularis germinal layer.

Parasitology international·2026

Local and systemic immune responses during rhBMP-2 mediated bone regeneration are dose-dependent in rat model of critical-sized bone defect healing.

Bone·2026

CAR-based immunotherapy for cardiac fibrosis: a new therapeutic frontier.

Ageing research reviews·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us